Summary of Principles of the International Strategy Meeting on Human Genome Sequencing (1996)
The following principles were endorsed by all participants. These included officers from, and scientists supported by, the Wellcome Trust, the U.K. Medical Research Council, the NIH NCHGR (National Center for Human Genome Research), the DOE (U.S. Department of Energy), the German Human Genome Programme, the European Commission, HUGO (Human Genome Organisation), and the Human Genome Project of Japan.
Primary Genomic Sequence Should Be in the Public Domain
It was agreed that all human genomic sequence information, generated by centres funded for large-scale human sequencing, should be freely available and in the public domain in order to encourage research and development and to maximise its benefit to society.
Primary Genomic Sequence Should Be Rapidly Released
- Sequence assemblies should be released as soon as possible; in some centres, assemblies of greater than 1 Kb would be released automatically on a daily basis.
- Finished annotated sequence should be submitted immediately to the public databases.
It was agreed that these principles should apply for all human genomic sequence generated by large-scale sequencing centres, funded for the public good, in order to prevent such centres establishing a privileged position in the exploitation and control of human sequence information. It was also agreed that patents should not be sought.